NeuShen Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase I Study of NS-079 in Healthy Participants (NCT07669571) | NeuShen Therapeutics | 2026-06-01 |
| A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia (NCT07521683) | NeuShen Therapeutics | 2025-10-20 |
| First-into-human Study of NS-136 in Healthy Subjects (NCT06345703) | NeuShen Therapeutics | 2024-04-30 |
Track NeuShen Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.